Literature DB >> 20535573

Metabolic changes through hypoxia in humans and in yeast as a comparable cell model.

Nikolaus C Netzer1, Michael Breitenbach.   

Abstract

BACKGROUND: In several investigations on mountaineers under moderate hypoxia, at altitudes between 2,500 m and 4,500 m, weight loss occurs, fat levels in the serum and insulin resistance (in diabetic mountaineers) are reduced. Animal studies with different time dosage regimens of hypoxia in animal cages revealed different and partly confusing results regarding fat metabolism under hypoxia. HYPOTHESES: Hypothesis for the change in glucose and fat metabolism include a HIF promoted higher leptin rate under hypoxia and an increased glucose transport in peripheral organs. DISCUSSION: This short review discusses some of the different investigations in this topic. In a second part it is shown how studies of metabolism in yeast cells with an upregulated glycolysis in the cell itself under hypoxic conditions could help to better understand metabolic changes under hypoxia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20535573     DOI: 10.1007/s11325-010-0342-7

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  32 in total

1.  Raised leptin concentrations at high altitude associated with loss of appetite.

Authors:  M Tschöp; C J Strasburger; G Hartmann; J Biollaz; P Bärtsch
Journal:  Lancet       Date:  1998-10-03       Impact factor: 79.321

2.  Operation Everest. II: Nutrition and body composition.

Authors:  M S Rose; C S Houston; C S Fulco; G Coates; J R Sutton; A Cymerman
Journal:  J Appl Physiol (1985)       Date:  1988-12

Review 3.  Nutrition and energetics of exercise at altitude. Theory and possible practical implications.

Authors:  B Kayser
Journal:  Sports Med       Date:  1994-05       Impact factor: 11.136

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Leptin, its implication in physical exercise and training: a short review.

Authors:  Anissa Bouassida; Dalenda Zalleg; Semi Bouassida; Monia Zaouali; Youssef Feki; Abdelkarim Zbidi; Zouhair Tabka
Journal:  J Sports Sci Med       Date:  2006-06-01       Impact factor: 2.988

Review 7.  Rox1 mediated repression. Oxygen dependent repression in yeast.

Authors:  A J Kastaniotis; R S Zitomer
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

8.  Major gene for percent of oxygen saturation of arterial hemoglobin in Tibetan highlanders.

Authors:  C M Beall; J Blangero; S Williams-Blangero; M C Goldstein
Journal:  Am J Phys Anthropol       Date:  1994-11       Impact factor: 2.868

9.  TOR signaling is a determinant of cell survival in response to DNA damage.

Authors:  Changxian Shen; Cynthia S Lancaster; Bin Shi; Hong Guo; Padma Thimmaiah; Mary-Ann Bjornsti
Journal:  Mol Cell Biol       Date:  2007-08-13       Impact factor: 4.272

10.  Low intense physical exercise in normobaric hypoxia leads to more weight loss in obese people than low intense physical exercise in normobaric sham hypoxia.

Authors:  Nikolaus C Netzer; Roland Chytra; Thomas Küpper
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

View more
  1 in total

1.  Spatial reorganization of Saccharomyces cerevisiae enolase to alter carbon metabolism under hypoxia.

Authors:  Natsuko Miura; Masahiro Shinohara; Yohei Tatsukami; Yasuhiko Sato; Hironobu Morisaka; Kouichi Kuroda; Mitsuyoshi Ueda
Journal:  Eukaryot Cell       Date:  2013-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.